Jul 16, 2026 04:05PM
Jul 1, 2026 04:05PM
Jun 16, 2026 04:00PM
May 28, 2026 07:05AM
May 5, 2026 04:05PM
Apr 28, 2026 09:05AM
Apr 16, 2026 04:05PM Protagonist Therapeutics Reports Granting of Inducement Awards
Mar 28, 2026 10:05AM
Mar 28, 2026 10:05AM
Mar 18, 2026 03:39PM
Mar 18, 2026 12:17PM
Mar 18, 2026 10:28AM
Mar 18, 2026 08:05AM
Mar 18, 2026 08:05AM Protagonist Therapeutics Announces U.S. FDA Approval of ICOTYDE(TM) (icotrokinra) for the Treatment of Moderate to Severe Plaque Psoriasis
Mar 2, 2026 06:01AM
Mar 2, 2026 02:00AM
Feb 25, 2026 05:15PM
Feb 25, 2026 04:05PM
Jan 30, 2026 06:47AM
Jan 5, 2026 07:03AM
Jan 5, 2026 07:00AM Takeda and Protagonist Announce Submission of New Drug Application (NDA) for Rusfertide for Treatment of Polycythemia Vera (PV)
Dec 12, 2025 04:54AM
Dec 8, 2025 02:54AM
Dec 6, 2025 09:30AM
Nov 6, 2025 04:05PM
Oct 7, 2025 11:00PM
Aug 7, 2025 04:18AM
Aug 6, 2025 04:05PM Protagonist Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Jun 1, 2025 08:00AM
Mar 3, 2025 01:28PM
Mar 3, 2025 06:46AM
Mar 3, 2025 06:45AM
Feb 21, 2025 07:00AM
Jan 6, 2025 04:05PM
Nov 7, 2024 04:05PM Protagonist Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Apr 16, 2024 09:00AM
Jan 31, 2024 04:09PM
Jan 31, 2024 04:05PM
Apr 4, 2023 05:41PM
Mar 15, 2023 04:01PM
Aug 4, 2022 04:05PM
May 4, 2022 04:05PM Protagonist Reports First Quarter 2022 Financial Results and Provides Corporate Update
Apr 26, 2022 08:54AM
Apr 13, 2022 05:11PM
Apr 12, 2022 09:00AM
Feb 11, 2022 06:01AM
Nov 4, 2021 07:00AM
Nov 3, 2021 04:05PM
Oct 12, 2021 06:10AM Protagonist Therapeutics (PTGX) Rusfertide's Clinical Hold is Lifted Faster Than Expected - Piper Sandler
Oct 11, 2021 09:21AM

326,366 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All